BRIDGEBIO PHARMA INC

CUSIP: 10806XAB8 Class: NOTE 2.500% 3/1

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 664,000 Value ($000) $1,253 Avg Close — Range —
Q3 2025
Shares 914,000 Value ($000) $1,283 Avg Close — Range —
Q2 2025
Shares 914,000 Value ($000) $1,143 Avg Close — Range —
Q1 2025
Shares 914,000 Value ($000) $1,042 Avg Close — Range —
Q4 2024
Shares 914,000 Value ($000) $957 Avg Close — Range —
Q3 2024
Shares 914,000 Value ($000) $943 Avg Close — Range —
Q2 2024
Shares 914,000 Value ($000) $924 Avg Close — Range —
Q1 2024
Shares 414,000 Value ($000) $445 Avg Close — Range —
Q4 2023
Shares 414,000 Value ($000) $500 Avg Close — Range —
Q3 2023
Shares 414,000 Value ($000) $398 Avg Close — Range —
Q2 2023
Shares 914,000 Value ($000) $712 Avg Close — Range —
Q1 2023
Shares 1,387,000 Value ($000) $1,033 Avg Close — Range —
Q4 2022
Shares 1,387,000 Value ($000) $629 Avg Close — Range —
Q3 2022
Shares 1,387,000 Value ($000) $818 Avg Close — Range —
Q2 2022
Shares 1,387,000 Value ($000) $754 Avg Close — Range —
Q1 2022
Shares 1,387,000 Value ($000) $821 Avg Close — Range —
Q4 2021
Shares 1,339,000 Value ($000) $970 Avg Close — Range —
Q3 2021
Shares 1,297,000 Value ($000) $1,790 Avg Close — Range —
Q2 2021
Shares 1,881,000 Value ($000) $3,089 Avg Close — Range —
Q1 2021
Shares 2,096,000 Value ($000) $3,492 Avg Close — Range —